Download FREE Report Sample
Download Free sampleThe growth can be attributed to recent developments in immuno-oncology, changes in lifestyle brought on by urbanization predisposing populations to the rise of cancer, and the growing acceptability of targeted therapy.
Immuno-oncology Clinical Trials Market contains market size and forecasts of Immuno-oncology Clinical Trials in Global, including the following market information:
Global Immuno-oncology Clinical Trials Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Immuno-oncology Clinical Trials market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Phase I Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immuno-oncology Clinical Trials include Medpace, Novartis, Exscientia, Syneous Health, AstraZeneca, ICON plc, IQVIA Holdings, BioNtech and Covance, Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Immuno-oncology Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immuno-oncology Clinical Trials Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Immuno-oncology Clinical Trials Market Segment Percentages, by Type, 2021 (%)
Phase I
Phase II
Phase III
Phase IV
Global Immuno-oncology Clinical Trials Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Immuno-oncology Clinical Trials Market Segment Percentages, by Application, 2021 (%)
Solid Tumors
Hematological Cancer
Global Immuno-oncology Clinical Trials Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Immuno-oncology Clinical Trials Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immuno-oncology Clinical Trials revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Immuno-oncology Clinical Trials revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medpace
Novartis
Exscientia
Syneous Health
AstraZeneca
ICON plc
IQVIA Holdings
BioNtech
Covance, Inc.
IO BIOTECH
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
